Skip to main content
. 2024 Nov 29;16(11):e74781. doi: 10.7759/cureus.74781

Table 2. Establishment of PDX from metastatic bone tumors.

PDX: patient-derived xenograft.

  Diagnosis Number of cases obtained Percentage of cases of metastatic bone tumors Number of PDX established / Number of cases (%)
1 Renal cell carcinoma 6 37.5 1/6 (16.7%)
2 Melanoma 3 18.75 3/3 (100%)
3 Lung cancer 2 12.5 2/2 (100%)
4 Breast cancer 2 12.5 0/2 (0%)
5 Carcinoma of unknown origin 1 6.25 1/1 (100%)
6 Thyroid cancer 1 6.25 0/1 (0%)
7 Prostate cancer 1 6.25 0/1 (0%)
  Total 16 100 7/16 (43.8%)